Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Palonosetron A04Aa05 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3992888

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Freesol Broad Agency Annoucement

Deadline: 22 Feb 2029

United States

Ref. No.: 3975293

EMD:Ref Document

Bid Value: Ref Document

1275 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Film Coated Tablets Excluding Potency 2 5Mg As Part Of A So Calle

Deadline: 31 Jan 2026

Germany

Ref. No.: 3943332

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Adalimumab L04Ab04 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940896

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Infliximab L04Ab02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940617

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredient Rivaroxaban B01Af01 With An Effective Strength Of 2 5 Mg Per Divided Dosage Form

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940204

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Hard Capsules Excluding Potency 2 5Mg As Part Of A So Called Open

Deadline: 31 Jan 2026

Germany

Ref. No.: 3939962

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Botulinum Toxin Type A M03Ax21 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3936784

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Etanercept L04Ab01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3934657

EMD:Ref Document

Bid Value: Ref Document

157 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Tafluprost And Timolol Atc Code S01Ed70

Deadline: 25 Jan 2026

Germany

Ref. No.: 3891624

EMD:Ref Document

Bid Value: Ref Document

151 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Drugs With The Active Ingredient Combination Of Oxycodone And Naloxone Atc Code N02Aa55

Deadline: 25 Jan 2026

Germany

Ref. No.: 3882987

EMD:Ref Document

Bid Value: Ref Document

151 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Ciclosporin Atc Code S01Xa18

Deadline: 25 Jan 2026

Germany

Ref. No.: 3882975

EMD:Ref Document

Bid Value: Ref Document

151 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dexamethasone Exclusively Imp Atc S01Ba01 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882718

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Open House Drug Discount Agreements Rivaroxaban With A Potency Of 2 5 Mg Film Coated Tablets And Hard Capsules Atc B01Af01

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882690

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882382

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Showing 26866 to 26880 of 26971 results

‹
1
2
...
1789
1790
1791
1792
1793
1794
1795
...
1798
1799
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!